Bruised Over Humira Patent Games, AbbVie Sees Smoother Road With Botox
Executive Summary
AbbVie’s proposed acquisition of Allergan unites two companies that have gained notoriety for their exhaustive and unconventional efforts, respectively, to extend the patents of key products.